1-(2-氟苯基)环已烷腈 | 106795-72-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(2-氟苯基)环已烷腈
• 中文别名: 1-(2-氟苯基)环己烷甲腈
• 英文名称: 1-(2-fluorophenyl)cyclohexane-1-carbonitrile
• 英文别名: 1-(2-fluorophenyl)cyclohexanecarbonitrile
• CAS: 106795-72-6
• 化学式: C₁₃H₁₄FN
• 分子量: 203.259
• InChiKey: NLLWMLADVNXWKT-UHFFFAOYSA-N

物化性质

• 沸点：
  130-135 °C(Press: 2.3 Torr)
• 密度：
  1.0708 (estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2926909090

SDS

Name:	1-(2-Fluorophenyl)cyclohexanecarbonitrile 95% Material Safety Data Sheet
Synonym:	None known
CAS:	106795-72-6

Section 1 - Chemical Product MSDS Name:1-(2-Fluorophenyl)cyclohexanecarbonitrile 95% Material Safety Data Sheet
Synonym:None known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
106795-72-6	1-(2-Fluorophenyl)cyclohexanecarbonitr	95%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be metabolized to cyanide which in turn acts by inhibiting cytochrome oxidase impairing cellular respiration.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated. Metabolism may release cyanide, which may result in headache, dizziness, weakness, collapse, unconsciousness and possible death.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Can produce delayed pulmonary edema. May be metabolized to cyanide which in turns act by inhibiting cytochrome oxidase impairing cellular respiration.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting cytochrome oxidase impairing cellular respiration. Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 106795-72-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H14FN
Molecular Weight: 203.1031

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 106795-72-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(2-Fluorophenyl)cyclohexanecarbonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 106795-72-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 106795-72-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 106795-72-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(2-氟苯基)环已烷腈 在 硫酸 、 lithium hydride 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 47.5h， 生成 螺[环己烷-1,3'-吲哚]-2'(1'H)-酮
  参考文献：
  名称：

  Fleming, Ian; Loreto, Maria Antonietta; Wallace, Ian H.M., Journal of the Chemical Society. Perkin transactions I, 1986, p. 349 - 360

  摘要：

  DOI：
• 作为产物：
  描述：

  1,5-二溴戊烷 、 2-氟苯基乙腈 在 氢氧化钾 作用下， 以 二甲基亚砜 为溶剂， 反应 24.0h， 以48%的产率得到1-(2-氟苯基)环已烷腈
  参考文献：
  名称：

  Fleming, Ian; Loreto, Maria Antonietta; Wallace, Ian H.M., Journal of the Chemical Society. Perkin transactions I, 1986, p. 349 - 360

  摘要：

  DOI：

文献信息

• Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
  申请人：Wilk Kazimierz Bogdan

  公开号：US20060247441A1

  公开（公告）日：2006-11-02

  Methods for preparing oxindole and thio-oxindole compounds are provided, which compounds are useful as precursors to useful pharmaceutical compounds. Specifically provided are methods for preparing 5-pyrrole-3,3-oxindole compounds and 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile. Also provided are methods for preparing iminobenzo[b]thiophene and benzo[b]thiophenone compounds.

  提供了制备氧吲哚和硫氧吲哚化合物的方法，这些化合物作为有用的药物化合物的前体。具体提供了制备5-吡咯-3,3-氧吲哚化合物和5-(7-氟-3,3-二甲基-2-氧代-2,3-二氢-1H-吲哚-5-基)-1-甲基-1H-吡咯-2-碳腈的方法。还提供了制备亚苄基苯并[b]噻吩和苯并[b]噻吩酮化合物的方法。
• SPIROINDOLINES AS MODULATORS OF CHEMOKINE RECEPTORS
  申请人：Budzik Brian W.

  公开号：US20110034499A1

  公开（公告）日：2011-02-10

  The present invention relates to a compound of the following formula: where R 1 -R 6 , R 10 , Y, n, m, p, and q are as defined herein. Compounds and compositions of the present invention are useful for the treatment of diseases associated with the overexpression of CCR2.

  本发明涉及以下式的化合物：其中R1-R6、R10、Y、n、m、p和q如本文所定义。本发明的化合物和组合物对于治疗与CCR2过度表达相关的疾病是有用的。
• FLEMING, I.;LORETO, M. A.;WALLACE, I. H. M.;MICHAEL, J. P., J. CHEM. SOC. PERKIN TRANS., 1986, N 2, 349-359
  作者：FLEMING, I.、LORETO, M. A.、WALLACE, I. H. M.、MICHAEL, J. P.

  DOI：——

  日期：——
• PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES
  申请人：Wyeth

  公开号：EP1877377A2

  公开（公告）日：2008-01-16
• THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES
  申请人：NV reMYND

  公开号：EP1981504B1

  公开（公告）日：2010-07-21